Page last updated: 2024-11-03

opc 12759 and Respiratory Tract Infections

opc 12759 has been researched along with Respiratory Tract Infections in 1 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.

Research Excerpts

ExcerptRelevanceReference
"Treatment with ambroxol, but not carbocisteine, significantly reduced the median number of AURD episodes (P=0."2.72Ambroxol for the prevention of acute upper respiratory disease. ( Fujimura, M; Ishiura, Y; Myou, S; Nakao, S; Nobata, K, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nobata, K1
Fujimura, M1
Ishiura, Y1
Myou, S1
Nakao, S1

Trials

1 trial available for opc 12759 and Respiratory Tract Infections

ArticleYear
Ambroxol for the prevention of acute upper respiratory disease.
    Clinical and experimental medicine, 2006, Volume: 6, Issue:2

    Topics: Aged; Aged, 80 and over; Alanine; Ambroxol; Carbocysteine; Female; Humans; Male; Quinolones; Respira

2006